M34 Systemic sclerosis [scleroderma]

Name of the Condition

• Systemic sclerosis [scleroderma]

Summary

Systemic sclerosis is a chronic autoimmune disease characterized by skin thickening and fibrosis, along with potential involvement of internal organs such as the lungs, heart, kidneys, and gastrointestinal tract. It results from abnormal immune activation and excessive collagen production, leading to tissue scarring and functional impairment.

Causes

The exact cause of systemic sclerosis is unknown, but it involves dysregulation of the immune system, genetic predisposition, and environmental triggers. Abnormal immune responses lead to inflammation and fibrosis, while genetic factors may increase susceptibility to disease development.

Risk Factors

• Female gender (more common in women).
• Age (typically onset between 30-50 years).
• Family history of autoimmune diseases.
• Exposure to certain environmental factors (e.g., silica, organic solvents).
• Ethnicity (higher prevalence in certain populations).

Symptoms

• Skin thickening and hardening, often starting in the hands and face.
• Raynaud's phenomenon (color changes in fingers/toes with cold or stress).
• Joint pain and stiffness.
• Gastrointestinal issues (e.g., acid reflux, bloating, difficulty swallowing).
• Lung problems (e.g., shortness of breath, cough).
• Kidney involvement (e.g., hypertension, renal crisis).
• Fatigue and weight loss.

Diagnosis

Diagnosis is based on clinical evaluation, including skin changes, organ involvement, and laboratory tests. Antinuclear antibodies (ANAs) and specific autoantibodies (e.g., anti-centromere, anti-Scl-70) support diagnosis. Imaging (e.g., X-rays, CT scans) and functional tests assess organ damage. Skin biopsy may confirm fibrosis.

Treatment Options

• Medications: Immunosuppressants (e.g., methotrexate), vasodilators (e.g., nifedipine), and endothelin receptor antagonists (e.g., bosentan) for organ-specific symptoms.
• Symptom Management: Treatments for Raynaud's phenomenon, acid reflux, and pulmonary hypertension.
• Physical Therapy: To maintain mobility and manage joint stiffness.
• Lifestyle Adjustments: Protecting extremities from cold and managing stress.

Prognosis and Follow-Up

Prognosis varies based on disease severity and organ involvement. Early diagnosis and treatment improve outcomes. Regular monitoring of organ function (e.g., lung, kidney) is essential. Follow-up includes clinical assessments, imaging, and laboratory tests to detect complications early.

Complications

• Pulmonary fibrosis or hypertension.
• Renal crisis (acute kidney injury).
• Cardiac issues (e.g., pericarditis, arrhythmias).
• Digital ulcers or gangrene.
• Malabsorption or motility disorders.
• Increased risk of certain cancers (e.g., lung cancer).

Lifestyle & Prevention

• Avoid smoking and limit alcohol.
• Protect skin from cold and trauma.
• Manage stress through relaxation techniques.
• Maintain a balanced diet and regular exercise.
• Stay up-to-date with vaccinations (e.g., flu, pneumonia).

When to Seek Professional Help

Seek care if experiencing worsening skin tightness, new organ symptoms (e.g., shortness of breath, chest pain), uncontrolled Raynaud's episodes, or signs of infection. Prompt evaluation is critical for managing acute complications like renal crisis.

Tips for Medical Coders

Document the extent of skin involvement (e.g., limited vs. diffuse) and organ system involvement (e.g., pulmonary, renal) to support code assignment. Include details on autoantibody results and diagnostic tests when available. Ensure documentation aligns with clinical findings to accurately reflect disease severity and progression.